½ÃÀ庸°í¼­
»óǰÄÚµå
1272776

¼¼°èÀÇ ¼º´ë È®´ë ½ÃÀå(2023-2030³â)

Global Vocal Fold Augmentation Market - 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½ÃÀå °³¿ä

¼¼°è ¼º´ë È®´ë ½ÃÀåÀº 2022³â 20¾ï 4,280¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2030³â¿¡´Â 26¾ï 4,280¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼º´ë È®´ë ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030) µ¿¾È 3.3%ÀÇ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº M&A, ÆÄÆ®³Ê½Ê, Áö¿ª È®Àå µîÀÇ Àü·«À» äÅÃÇÏ¿© ¼º´ë °­È­ ½Ã¿¡¼­ °­·ÂÇÑ °æÀïÀÚ·Î ºÎ»óÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ³ë·Â°ú ÇÔ²² ½ÅÁ¦Ç° Ãâ½Ã´Â ÁÖ¿ä ±â¾÷µéÀÌ ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇÏ´Â ¶Ç ´Ù¸¥ ¹æ¹ýÀÔ´Ï´Ù.

¿¹¸¦ µé¾î, 2020³â 11¿ù 6ÀÏ, Thyssen'sche Handelsgesellschaft mbH(THG)´Â SPIGGLE &THEIS Medizintechnik GmbH("SPIGGLE &THEIS")ÀÇ °ú¹Ý¼ö ÁöºÐÀ» Áï½Ã ÃëµæÇß½À´Ï´Ù. ¶ÇÇÑ 2020³â 12¿ù 18ÀÏ, ¿¡ÀÌÇÁ·»Æ®¿Í hearLIFE´Â Çѱ¹, ½Ì°¡Æ÷¸£, ¸»·¹À̽þÆ, ű¹, Àεµ³×½Ã¾Æ, º£Æ®³², įº¸µð¾Æ, ¶óÀå¿À½º, ¶ó¿À½º, ¹Ì¾á¸¶, ºê·ç³ªÀÌ¿¡¼­ ¿¡ÀÌÇÁ·»Æ® VOISÀÇ µ¶Á¡ ÆÇ¸Å °è¾àÀ» ü°áÇÏ¿´½À´Ï´Ù.

½ÃÀå ÁøÃâ±â¾÷µéÀÇ Áö¸®Àû ÀÔÁö È®´ë, ¿©·¯ Á¦Ç° Ãâ½Ã ¹× ½ÅÈï ½ÃÀå °³Ã´À» ÅëÇÑ °í°´Ãþ °­È­¿Í °°Àº °æÀï ¿äÀÎÀÌ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼º´ë È®´ë´Â ¼º´ë ±â´ÉÀ» °­È­Çϱâ À§ÇØ ½ÃÇàµÇ´Â ÀÇ·á ½Ã¼úÀÔ´Ï´Ù. ¼º´ë À§Ãà, ¸¶ºñ, ¸¶ºñ¿Í °°Àº °æÁõ¿¡¼­ ÁߵÀÇ ¼º¹® Æó¼â ºÎÀüÀÇ ´Ù¾çÇÑ ¿µ±¸Àû ÀÎ ¿øÀÎÀ» Ä¡·áÇϱâ À§ÇØ ¼º´ë Áֻ縦 »ç¿ëÇÏ´Â °ÍÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ ÀÌÀü Ʋ ¼ö¼ú ÈÄ °­È­¿¡µµ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼°è ¼º´ë È®´ëÁ¦ ½ÃÀåÀº À½¼º °ü·Ã ¹®Á¦ »ç·Ê Áõ°¡, °Ç°­ °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ±â¼ú ¹ßÀü µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ³ë·É Àα¸ Áõ°¡¿Í ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, Áö³­ 10³â°£ ¼º´ë Áֻ簡 ´Ù¾çÇÑ ÈĵΠÁúȯ¿¡ ´ëÇÑ ±ÍÁßÇÑ Ä¡·á¹ýÀ¸·Î µîÀåÇÑ °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÈÄµÎ¾Ï È¯ÀÚ ¼ö Áõ°¡´Â ¼º´ë È®´ëÁ¦ ¼¼°è ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»ó

¼¼°è ¼º´ë È®´ë ½ÃÀåÀº ÈĵξÏÀ» Æ÷ÇÔÇÑ À½¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ¼ºÀåÀÌ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ¾ÏÇùȸ¿¡ µû¸£¸é ¸Å³â ¾à 13,150°ÇÀÇ ÈĵξÏÀÌ »õ·Î ¹ß»ýÇϸç, HPV °¨¿°, Èí¿¬, À½ÁÖ µîÀÇ À§Çè ¿äÀÎÀÌ Áõ°¡ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÈĵΠÁúȯ ȯÀÚÀÇ ¹ß¼º ±â´ÉÀ» °³¼±Çϱâ À§ÇÑ ¼º´ë È®´ë¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¼¼°è ¼º´ë È®´ë ½ÃÀåÀº ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·À¸·Î ÀÎÇÑ Á¦¾à¿¡ Á÷¸éÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼º´ë È®´ë ½ÃÀåÀº ¾çÁúÀÇ ÀÇ·á Àη¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á Àη ºÎÁ·ÀÇ ¿µÇâÀ» ¹Þ°Ô µÇ´Âµ¥, usnews.com¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â 2025³â±îÁö ȨÇïÆÛ, °£È£Á¶¹«»ç, ÀÇ·á ¹× °Ë»ç ±â¼úÀÚ ¹× ±â¼úÀÚ, °£È£»ç µî ¿©·¯ ÀÇ·á Àü¹®Á÷ÀÇ ºÎÁ·¿¡ Á÷¸éÇÒ °ÍÀ¸·Î ¿¹»ó °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ·¯ÇÑ ºÎÁ·Àº ƯÁ¤ Á÷¾÷¿¡¼­ °¡Àå µÎµå·¯Áö°í ±ØÀûÀ¸·Î ³ªÅ¸³ª¸ç, ¼º´ë ¼ºÇü¼ú°ú Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃæÁ·½ÃŰ´Â µ¥ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

Äڷγª19ÀÇ ¿µÇ⠺м®

Äڷγª19´Â ¼¼°è ¼º´ë È®´ë ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÄ ÀÇ·á±â±â ¹× Àåºñ°ø±Þ¸Á°ú Á¦Á¶¿¡ È¥¶õÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ±× °á°ú Áö¿¬°ú ºÎÁ·ÀÌ ¹ß»ýÇÏ¿© ½ÃÀå¿¡¼­ Á¦Ç° ¹× ¼­ºñ½º È®º¸¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¶ÇÇÑ, ¸¹Àº ÀÇ·á ½Ã¼³¿¡¼­ Äڷγª19 ȯÀÚ¸¦ ¿ì¼±½ÃÇÏ°í °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¼º´ë È®´ë ¼ö¼úÀ» Æ÷ÇÔÇÑ ¼±ÅÃÀû ½Ã¼úÀ» Ãà¼ÒÇϰųª ¿¬±âÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ÀÌ·¯ÇÑ ¾î·Á¿ò¿¡µµ ºÒ±¸Çϰí, À½¼º Àå¾ÖÀÇ À¯º´·ü Áõ°¡¿Í Çõ½ÅÀûÀÎ ¼ö¼ú ±â¼ú ¹× ½ÅÁ¦Ç°¿¡ ´ëÇÑ ½ÃÀå ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÆÒµ¥¹Í »óȲÀÌ °³¼±µÇ¸é ½ÃÀåÀÌ È¸º¹µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¸¹Àº Á¦Á¶¾÷ü¿Í ¼­ºñ½º Á¦°ø¾÷üµéÀÌ ¿ø°Ý ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÇ·á Àü¹®°¡¸¦ À§ÇÑ °¡»ó ±³À° ¹× Áö¿ø ÇÁ·Î±×·¥À» °³¹ßÇÔÀ¸·Î½á ÆÒµ¥¹Í¿¡ ÀûÀÀÇϰí ÀÖ½À´Ï´Ù.

·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀï ºÐ¼®

ÇöÀç ·¯½Ã¾Æ¿Í ¿ìÅ©¶óÀ̳ªÀÇ ºÐÀïÀº Á¦Á¶ ¹× À¯Åë °æ·Î¸¦ Â÷´ÜÇÔÀ¸·Î½á ¼º´ë È®´ë ½ÃÀå¿¡ °£Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ °ø±Þ ºÎÁ·°ú Á¦Ç° ºñ¿ë »ó½ÂÀÌ ¹ß»ýÇÏ¿© Áß¼Ò±â¾÷¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

±×·¯³ª ÀÌ·¯ÇÑ ¾î·Á¿ò¿¡µµ ºÒ±¸Çϰí, ÇコÄɾ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í À½¼º °ü·Ã ÁúȯÀÇ À¯º´·üÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀº Àå±âÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â µ¿Á¾¾÷°è¿¡ ºñÁî´Ï½º ±âȸ¸¦ °¡Á®´Ù ÁÙ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀüÀï°ú ÁøÇà ÁßÀÎ ÆÒµ¥¹ÍÀÇ ´Ü±âÀûÀÎ ¿µÇâÀº È¥¶õÀ» ¾ß±âÇÒ ¼ö ÀÖÁö¸¸, Àå±âÀûÀ¸·Î´Â ½ÃÀåÀÌ È¸º¹µÇ°í °è¼Ó ¹øÃ¢ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µû¶ó¼­ ºÐÀïÀÌ ¼¼°è ÇコÄÉ¾î »ê¾÷ Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÃßÀûÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

  • Á¶»ç ¹æ¹ý
  • Á¶»ç ¸ñÀû ¹× Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

  • ¼ÒÀç À¯Çüº° °³¿ä
  • Æ®¸®Æ®¸ÕÆ® À¯Çüº°
  • ÃÖÁ¾»ç¿ëÀÚº°
  • Áö¿ªº° °³¿ä

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • PorterÀÇ Five Forces ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ¹ý±ÔÁ¦ ºÐ¼®

Á¦6Àå COVID-19 ºÐ¼®

  • COVID-19 ºÐ¼®
    • COVID-19 µîÀå ÀÌÀüÀÇ ½Ã³ª¸®¿À
    • ÇöÀçÀÇ ½Ã³ª¸®¿À
    • COVID-19 ÀÌÈÄ ¶Ç´Â ÇâÈÄÀÇ ½Ã³ª¸®¿À
  • COVID-19 ±â°£ÀÇ °¡°Ý ¹× ¿ªÇÐ
  • ¼ö±Þ ½ºÆåÆ®·³
  • ÆÒµ¥¹Í ±â°£ÀÇ ½ÃÀå¿¡ °ü·ÃµÈ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
  • Á¦Á¶¾÷üÀÇ Àü·«ÀûÀÎ ÀÌ´Ï¼ÅÆ¼ºê
  • ¿ä¾à

Á¦7Àå ¼ÒÀç À¯Çüº°

  • Ä«º¹½Ã¸ÞÆ¿¼¿·ê·Î¿À½º
  • Ä®½· ÇÏÀ̵å·Ï½Ã¾ÆÆÄŸÀÌÆ®
  • È÷¾Ë·ç·Ð»ê
  • ½ÇÅ©
  • Á© Æû
  • À¯Áö·ù
  • ±âŸ

Á¦8Àå Ä¡·á À¯Çüº°

  • ÀϽÃÀû
  • Ç×±¸Àû

Á¦9Àå ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Àü¹®ÀÇ¿ø
  • ±âŸ

Á¦10Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • °æÀï ½Ã³ª¸®¿À
  • ½ÃÀå ÇöȲ/Á¡À¯À² ºÐ¼®
  • ÀμöÇÕº´(M&A) ºÐ¼®

Á¦12Àå ±â¾÷ °³¿ä

  • Merz Holding GmbH & Co KG(Merz Pharmaceuticals, LLC)
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü »óȲ
  • Sofregen Medical Inc.
  • Hoya Corporation(PENTAX Medical America, Inc.)
  • SPIGGLE & THEIS Medizintechnik GmbH
  • Inhealth Technologies
  • APrevent Medical Inc.
  • Boston Medical Products, Inc.
  • ReGen Scientific

Á¦13Àå ºÎ·Ï

LSH 23.05.22

Market Overview

The global vocal fold augmentation market reached US$ 2,042.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,642.8 million by 2030. The vocal fold augmentation market is expected to exhibit a CAGR of 3.3% during the forecast period (2023-2030). The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the vocal fold augmentation market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.

For instance, on November 6, 2020, Thyssen'sche Handelsgesellschaft mbH (THG) acquired a majority stake in SPIGGLE & THEIS Medizintechnik GmbH ("SPIGGLE & THEIS") with immediate effect. Moreover, on December 18, 2020, APrevent and hearLIFE signed the exclusive distribution agreement for APrevent VOIS in Korea, Singapore, Malaysia, Thailand, Indonesia, Vietnam, Cambodia, Laos, Myanmar, and Brunei.

Fierce competition between market participants to expand their geographic footprints and strengthen their customer pool through several product launches & new product developments are major factors anticipated to drive market growth over the forecast period.

Vocal fold augmentation is a medical procedure that is performed to enhance the functioning of the vocal folds. It involves the use of vocal fold injection to treat various permanent causes of mild-to-moderate glottic insufficiency, such as vocal fold atrophy, paralysis, and paresis. Moreover, it can also be used for augmentation after previous framework surgery.

The global vocal fold augmentation market is expected to experience significant growth in the coming years, driven by various factors such as increasing cases of voice-related problems, rising awareness of healthcare, and advancements in technology.

Moreover, the growing geriatric population and rising demand for minimally invasive procedures are also expected to boost the market's growth. The emergence of vocal fold injection as a valuable treatment modality for a variety of laryngeal disorders in the past decade is also contributing to the market's growth.

Market Dynamics

The rising number of laryngeal cancer cases is expected to drive the growth of the global vocal fold augmentation market

The global vocal fold augmentation market is being driven by the increasing prevalence of voice problems, including laryngeal cancer. For instance, The American Cancer Society reports that there are around 13,150 new cases of laryngeal cancer each year, with risk factors such as HPV infection, tobacco use, and alcohol consumption contributing to the rise in cases. As a result, there is an increasing demand for vocal fold augmentation procedures to improve vocal function in patients with laryngeal disorders.

The global vocal fold augmentation market growth may face constraints due to a lack of skilled professionals

The vocal fold augmentation market is also affected by shortages in the healthcare workforce, as the demand for quality healthcare professionals increases. According to usnews.com, the U.S. is estimated to face shortages in several healthcare professions by 2025, including home health aides, nursing assistants, medical and lab technologists and technicians, and nurse practitioners. These shortages are most apparent and dramatic in certain professions, which could lead to challenges in meeting the demand for vocal fold augmentation procedures and treatments.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global vocal fold augmentation market, causing disruptions in the supply chain and manufacturing of medical devices and equipment. This has resulted in delays and shortages, affecting the availability of products and services in the market. Moreover, many healthcare facilities have reduced or postponed elective procedures, including vocal fold augmentation surgeries, to prioritize COVID-19 patients and reduce the risk of transmission.

However, despite these challenges, the market is expected to recover as the pandemic situation improves, driven by the growing prevalence of voice disorders and the increasing demand for innovative surgical techniques and new products in the market. Many manufacturers and service providers have also adapted to the pandemic by offering telemedicine services and developing virtual training and support programs for healthcare professionals.

Russia-Ukraine Conflict Analysis

The current conflict between Russia and Ukraine could have an indirect effect on the vocal fold augmentation market by interrupting the manufacturing and distribution channels, resulting in shortages of supplies and higher costs for products that could have a greater impact on smaller firms.

However, despite these challenges, the market is projected to expand in the long run due to a growing awareness of healthcare and the rising prevalence of voice-related disorders. This is expected to create business opportunities for companies in the industry. Although the short-term effects of the war and the ongoing pandemic may cause disruptions, the market is predicted to rebound and continue to thrive over time. As a result, it is crucial to track the impact of the conflict on the global healthcare industry as a whole.

Segment Analysis

The global vocal fold augmentation market is segmented based on material type, treatment type, end user, and region.

The carboxymethylcellulose segment is expected to hold the highest vocal fold augmentation market share

The carboxymethylcellulose segment is expected to be the dominant segment in the global vocal fold augmentation market, holding 30.7% of the market share over the forecast period. The use of carboxymethylcellulose vocal cord injection is expected to be the leading technique in the global vocal fold augmentation market. Carboxymethylcellulose (CMC) is a thickening agent derived from cellulose obtained from materials such as wood pulp or cotton lint, which is reacted with a derivative of acetic acid (found in vinegar) and is also referred to as cellulose gum.

Gels made from carboxymethylcellulose (CMC) and cross-linked hyaluronic acid are commonly used as injectable materials for temporary or resorbable vocal fold medialization. For example, PROLARYN GEL, an aqueous/glycerin/carboxymethylcellulose gel implant, is used to augment the size of displaced or deformed vocal folds so that they can meet the opposing fold in the midline, leading to improved phonation. PROLARYN GEL is particularly suitable for short-term vocal fold augmentation or for patients who want to evaluate augmentation before undergoing long-term procedures.

Geographical Analysis

The presence of major players to dominate the North America region.

The vocal fold augmentation market is expected to grow significantly in North America region over the forecast period due to the presence of key market players who hold a major global vocal fold augmentation market share of around 2/5th and also due to an increase in cases of vocal fold paresis or paralysis (VFP) caused by COVID-19 vaccination, leading to dysphonia and respiratory distress.

To address these issues, several companies, such as Sofregen Medical, Inc., are developing products like Silk Voice, a soft tissue bulking agent injection that helps with vocal fold medialization and insufficiency. Silk Voice injection helps improve phonation by increasing the size of the displaced or malformed vocal fold, allowing it to converge with the opposing fold at the midline. An urgent indication for Silk Voice injection could be vocal fold insufficiency and severe aspiration issues.

Competitive Landscape

The major global players in the market include Merz Holding GmbH & Co KG(Merz Pharmaceuticals, LLC), Sofregen Medical Inc., Hoya Corporation(PENTAX Medical America, Inc.), SPIGGLE & THEIS Medizintechnik GmbH, Inhealth Technologies, APrevent Medical Inc., and Boston Medical Products, Inc., among others.

Why Purchase the Report?

  • To visualize the global vocal fold augmentation- market segmentation based on material type, treatment type, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vocal fold augmentation market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vocal fold augmentation market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material Type
  • 3.2. Snippet by Treatment Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising number of laryngeal cancer cases is expected to drive the growth of the global vocal fold augmentation market.
    • 4.1.2. Restraints
      • 4.1.2.1. The global vocal fold augmentation market growth may face constraints due to lack of skilled professionals.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Carboxymethylcellulose
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Calcium Hydroxylapatite
  • 7.4. Hyaluronic Acid
  • 7.5. Silk
  • 7.6. Gelfoam
  • 7.7. Fats
  • 7.8. Others

8. By Treatment Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 8.1.2. Market Attractiveness Index, By Treatment Type
  • 8.2. Temporary
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Permanent

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Merz Holding GmbH & Co KG (Merz Pharmaceuticals, LLC) *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Sofregen Medical Inc.
  • 12.3. Hoya Corporation (PENTAX Medical America, Inc.)
  • 12.4. SPIGGLE & THEIS Medizintechnik GmbH
  • 12.5. Inhealth Technologies
  • 12.6. APrevent Medical Inc.
  • 12.7. Boston Medical Products, Inc.
  • 12.8. ReGen Scientific

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦